Technology
Health
Pharmaceutical

Eyegate Pharmaceuticals

$0.23
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.005 (2.22%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell EYEG and other stocks, options, ETFs, and crypto commission-free!

About

Eyegate Pharmaceuticals, Inc. Common Stock, also called Eyegate Pharmaceuticals, is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Read More Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

Employees
11
Headquarters
Waltham, Massachusetts
Founded
1998
Market Cap
10.48M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
587.66K
High Today
$0.23
Low Today
$0.2194
Open Price
$0.221
Volume
139.89K
52 Week High
$0.86
52 Week Low
$0.2153

Collections

Technology
Health
Pharmaceutical
Medical
2015 IPO
US
North America

News

Associated PressMay 8

EyeGate Pharma Reports First Quarter 2019 Financial Results and Provides Business Update

507

Earnings

-$0.24
-$0.16
-$0.07
$0.01
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 2, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.